Literature DB >> 8914854

Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.

P K Powell1, I Wolf, J M Lasker.   

Abstract

Human liver microsomes are capable of oxidizing lauric acid (laurate), a model medium-chain fatty acid, at both the omega- and omega-1 positions to form 12- and 11-hydroxylaurate, respectively. These laurate hydroxylation reactions are apparently catalyzed by distinct P450 enzymes. While the P450 responsible for microsomal laurate omega-1 hydroxylation in human liver has been identified as CYP2E1, the enzyme catalyzing omega-hydroxylation remains poorly defined. To that end, we employed conventional purification and immunochemical techniques to characterize the major hepatic laurate omega-hydroxylase in humans. Western blotting with rat CYP4A1 antibodies was used to monitor a cross-reactive P450 protein (M(r) = 52 kDa) during its isolation from human liver microsomes. The purified enzyme (7.4 nmol P450/mg protein) had an NH2-terminal amino acid sequence identical to that predicted from the human CYP4A11 cDNA over the first 20 residues found. Upon reconstitution with P450 reductase and cytochrome b5, CYP4A11 proved to be a potent laurate omega-hydroxylase, exhibiting a turnover rate of 45.7 nmol 12-hydroxylaurate formed/min/nmol P450 (12-fold greater than intact microsomes), while catalyzing the omega-1 hydroxylation reaction at much lower rates (5.4 nmol 11-hydroxylaurate formed/min/nmol P450). Analysis of the laurate omega-hydroxylation reaction in human liver microsomes revealed kinetic parameters (a lone Km of 48.9 microM with a VMAX of 3.72 nmol 12-hydroxylaurate formed/min/nmol P450) consistent with catalysis by CYP4A11. In fact, incubation of human liver microsomes with antibodies raised to CYP4A11 resulted in nearly 85% inhibition of laurate omega-hydroxylase activity while omega-1 hydroxylase activity remained unaffected. Furthermore, a strong correlation (r = 0.89; P < 0.001) was found between immunochemically determined CYP4A11 content and laurate omega-hydroxylase activity in liver samples from 11 different subjects. From the foregoing, it appears that CYP4A11 is the principle laurate omega-hydroxylating enzyme expressed in human liver.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914854     DOI: 10.1006/abbi.1996.0501

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Highly polymorphic human CYP4A11 gene.

Authors:  Byeong Hoon Cho; Byung Lae Park; Lyoung Hyo Kim; Hyun Sub Chung; Hyoung Doo Shin
Journal:  J Hum Genet       Date:  2005-05-14       Impact factor: 3.172

2.  Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.

Authors:  Vandana Hirani; Anton Yarovoy; Anita Kozeska; Ronald P Magnusson; Jerome M Lasker
Journal:  Arch Biochem Biophys       Date:  2008-07-16       Impact factor: 4.013

3.  20-Hydroxyeicosatetraenoic Acid (HETE)-dependent Hypertension in Human Cytochrome P450 (CYP) 4A11 Transgenic Mice: NORMALIZATION OF BLOOD PRESSURE BY SODIUM RESTRICTION, HYDROCHLOROTHIAZIDE, OR BLOCKADE OF THE TYPE 1 ANGIOTENSIN II RECEPTOR.

Authors:  Üzen Savas; Shouzou Wei; Mei-Hui Hsu; John R Falck; F Peter Guengerich; Jorge H Capdevila; Eric F Johnson
Journal:  J Biol Chem       Date:  2016-06-13       Impact factor: 5.157

4.  Opposing roles of peroxisome proliferator-activated receptor alpha and growth hormone in the regulation of CYP4A11 expression in a transgenic mouse model.

Authors:  Uzen Savas; Daniel E W Machemer; Mei-Hui Hsu; Pryce Gaynor; Jerome M Lasker; Robert H Tukey; Eric F Johnson
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

5.  A male-specific fatty acid omega-hydroxylase, SXE1, is necessary for efficient male mating in Drosophila melanogaster.

Authors:  Shinsuke Fujii; Akemi Toyama; Hubert Amrein
Journal:  Genetics       Date:  2008-08-20       Impact factor: 4.562

6.  Association study and expression analysis of CYP4A11 gene copy number variation in Chinese cattle.

Authors:  Mingjuan Yang; Jingqiao Lv; Liangzhi Zhang; Mingxun Li; Yang Zhou; Xianyong Lan; Chuzhao Lei; Hong Chen
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

Review 7.  Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications.

Authors:  Yazun Bashir Jarrar; Su-Jun Lee
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

8.  20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway.

Authors:  Stephanie Eid; Rita Maalouf; Ayad A Jaffa; Joseph Nassif; Ahmed Hamdy; Awad Rashid; Fuad N Ziyadeh; Assaad A Eid
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

9.  Kinetic analysis of lauric acid hydroxylation by human cytochrome P450 4A11.

Authors:  Donghak Kim; Gun-Su Cha; Leslie D Nagy; Chul-Ho Yun; F Peter Guengerich
Journal:  Biochemistry       Date:  2014-09-19       Impact factor: 3.162

10.  Xanthates As Useful Probes for Testing the Active Sites of Cytochromes P450 4A11 and 2E1.

Authors:  Tsveta Stoyanova; Iglika Lessigiarska; Momir Mikov; Ilza Pajeva; Stanislav Yanev
Journal:  Front Pharmacol       Date:  2017-09-22       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.